Togo vs United Kingdom: The number of people with susceptibility test result for rifampicin
Togo
1,805
in 2021
United Kingdom
1,734
in 2021
Togo rank
52nd
United Kingdom rank
54th
The number of people with susceptibility test result for rifampicin over time
- Togo
- United Kingdom
How they compare
Togo currently reports 1,805 against 1,734 in United Kingdom, a difference of 71.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was United Kingdom ahead.
Togo ranks 52nd and United Kingdom ranks 54th of 155 countries.
Across the 2 decades both report, Togo averaged higher in 1 and United Kingdom in 1.
Head to head by decade
| Decade | Togo | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 732 | 1,947 | 1,215 | United Kingdom |
| 2020s | 1,709 | 1,640 | 69 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Togo or United Kingdom?
- Togo, at 1,805 against 1,734 in United Kingdom as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Togo and United Kingdom?
- 71, with Togo ahead.
- How many years of comparable data are there for Togo and United Kingdom?
- 5 years are reported by both, from 2017 to 2021.
- How do Togo and United Kingdom rank globally for the number of people with susceptibility test result for rifampicin?
- Togo ranks 52nd and United Kingdom ranks 54th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.